Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$84.98 - $122.67 $184,576 - $266,439
2,172 New
2,172 $245,000
Q2 2022

Aug 18, 2022

SELL
$67.99 - $132.89 $36,918 - $72,159
-543 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$80.99 - $107.93 $43,977 - $58,605
543 New
543 $271,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Systematic Alpha Investments, LLC Portfolio

Follow Systematic Alpha Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Alpha Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Alpha Investments, LLC with notifications on news.